Simultaneously, Maxor announced its strategic combination with ProxsysRx, further accelerating the growth of Maxor’s Pharmacy Services segment and positioning Maxor as the largest independent provider of pharmacy management services to health systems, hospitals, clinics, and other provider organizations.

Ms. Tzoumakas is a seasoned executive with more than 25 years of strategic and operational leadership experience within the healthcare sector. Most recently, Ms. Tzoumakas served as CEO of RAYUS Radiology, a leading national provider of advanced diagnostic and interventional radiology services.  Ms. Tzoumakas has a proven track record of not only driving strategic growth and financial and operational results, but also in building great cultures and organizations.   

“Founded almost 100 years ago, Maxor has built a strong reputation over many decades for excellence in pharmacy care, with a unique set of capabilities that drive significant value for its clients,” said Ms. Tzoumakas. “I am honored to have the opportunity to succeed Mike Ellis and lead the organization into its next phase of growth, and I couldn’t be more excited about the tremendous opportunity ahead of us.”

“ProxsysRx combining with Maxor marks an exciting step forward in our focus on delivering comprehensive and integrated pharmacy care solutions to our health system and provider clients,” said Ms. Tzoumakas. “As health systems continue to experience a challenging and dynamic operating environment, our clients are looking for ways to maximize the value generated from their pharmacy service lines. In growing our Pharmacy Services business with the addition of ProxsysRx, we are bringing new and expanded solutions to our partners that deliver both clinical and financial value.”  

Hospital and health system clients of both Maxor and ProxsysRx will now have a full spectrum of pharmacy management solutions in one Pharmacy Services organization with end-to-end capabilities across specialty and retail pharmacy management, 340B optimization, and manufacturer and payer support services. Together with PBM solutions delivered through MaxorPlus, these clients are now able to fully integrate their pharmacy service lines with their pharmacy benefit strategies to improve patient access, affordability and outcomes while mitigating annual benefit cost increases.

“I’m incredibly excited about this new chapter with Maxor,” said George Salem, CEO of ProxsysRx. “Our organizations have a shared commitment to innovation and delivering exceptional client service and patient care. In joining forces with Maxor, we can bring new capabilities and resources to serve our clients in expanded ways.”  Mr. Salem will transition to a Board Observer role with Maxor, while working closely with Ms. Tzoumakas and the entire Maxor leadership team on maintaining the ProxsysRx commitment to its health care clients.

About Maxor

Maxor is a leading pharmacy care solutions company dedicated to improving patient outcomes and lowering the total cost of care through our clinically integrated set of pharmacy care services. Our teams help optimize the pharmacy experience for patients, our customers, their employees, and members whether it’s through our customized pharmacy benefit offerings; providing access to prescription medications and therapies through our home delivery and specialty pharmacies; or delivering clinical and financial value with our end-to-end pharmacy management solutions. With a legacy of exceptional service and deep clinical and pharmacy expertise, Maxor has been a trusted partner enabling pharmacy care since 1926.

Learn more at Maxor.com.

About ProxsysRx

ProxsysRx offers hospital systems proven solutions for optimizing pharmacy services’ positive impact on the continuum of care. Their solutions range from management of 340B prescription-savings programs, retail and specialty pharmacy operations, to prescription benefits program management, and patient financial assistance. ProxsysRx’s services are available on an integrated-program basis, or in individual components, and are supported by the company’s proprietary software system, which places actionable data and business intelligence at clients’ fingertips, in real-time.

Link to Official Press Release

The post Maxor announces the appointment of Kim Tzoumakas as new CEO and its strategic combination with ProxsysRx appeared first on VytlOne.

A newly released industry survey report from Maxor, a leading pharmacy solutions company, finds that hospitals and health systems can create significant value for their patients, clinicians, and organization by transforming their pharmacy services and operations. Maxor commissioned Sage Growth Partners to independently recruit and survey 78 executives and pharmacy leaders at hospitals and health systems in Q2 of 2024.

With healthcare costs projected to continue rising in 2025 and beyond and talent shortages taxing hospital pharmacy services, today’s hospital and health system C-suites are closely examining multiple ways to streamline operations, drive efficiencies, and generate additional revenue sources. The new report, Hospital Leaders Are Transforming Pharmacy Services from Cost Centers to Revenue Streams: Opportunities & Obstacles, brings to light where health systems are failing to capitalize on value creation opportunities within their pharmacies.

“Our research shows that those traditional ways of thinking are changing. The survey findings show that nearly two-thirds of responding organizations plan to expand pharmacy services by opening new sites but it’s challenging to effectively do that work alone,” said Mike Ellis, CEO of Maxor National Pharmacy Services. “This research underscores how working with a strategically aligned pharmacy partner can unlock clinical and financial value for health systems.”

The biggest risk health system leaders face is not taking action to transform pharmacy services into strategic assets. “The risks of inaction are clear: suboptimal and underutilized pharmacy assets, avoidable prescription leakage, fragmented patient care, poor clinical outcomes, increased readmissions, and channel competition with large, vertically integrated  vendors,” said Joel Wright, President of Maxor’s Pharmacy Services. “Our research illustrates the power of partnering to develop integrated pharmacy strategies supported by an ecosystem of care that creates value for the organization and improves adherence rates and health outcomes for patients.”

This research also shows the undeniable power of pharmacy solution-specific partnerships. Seventy-two percent of surveyed health systems that have aligned with external pharmacy services partners expressed that they capitalize well on revenue generation opportunities – compared to just 32% that do not work with an external partner.

“Leaders should also focus on identifying the revenue and cost savings opportunities that exist at their current sites,” said Dan D’Orazio, CEO of Sage Growth Partners. “Addressing gaps in patient care and unmet partnership potential could easily drive increased cost savings and more efficient, effective revenue capture.”

Other key findings of the report include:

• 62% of survey respondents said that their organization plans to expand pharmacy services through the opening of new sites
• 29% of those surveyed indicated they are “very confident” to meet the demand of pharmacy services over the next three to five years
• Fewer than one-third (28%) of survey respondents said that their health system currently has real-time data to support a detailed understanding of script leakage and three quarters (73%) expressed interest in leveraging data to gain those insights
• 50% of respondents either don’t know their organization’s pharmacy capture rate or report that it is under 30% – indicating substantive opportunities for improvement

The full market report and survey can be found here.

Related Links

• Link to Official Press Release
• Realizing the value of pharmacy with an integrated pharmacy strategy

The post New Research Reveals More Hospital and Health System C-Suites are Transforming Pharmacy Services in the Next 3-5 years appeared first on VytlOne.

“We are honored to receive this recognition for the fourth time,” said Jen Gallego, President of MaxorPlus. “This award is a testament to the relentless dedication, passion, and commitment of our employees, especially our Arizona leadership team. Their efforts, along with those of our talented and diverse team, drive us to provide exceptional service and value to our clients and members. We take great pride in their contributions, which make MaxorPlus an outstanding place to work and grow.”

MaxorPlus is a leader in the PBM industry, providing innovative and customized solutions to employers, hospitals, and government entities. MaxorPlus offers a full spectrum of services, including formulary management, clinical programs, specialty pharmacy, mail order, and network management. By leveraging advanced technology, data analytics, and clinical expertise, MaxorPlus optimizes outcomes and reduces costs for its clients and members.

The AZ Central Top Workplace Award is an annual program that recognizes the best employers in Arizona based on the opinions of their employees. The award is organized by The Arizona Republic and azcentral.com, in partnership with Energage, a research firm that specializes in organizational health and workplace improvement. The award is open to any organization with 50 or more employees in Arizona, and the winners are selected from thousands of nominations.

Related Links

• Link to Official Press Release
• 340B Report Sponsored Article: PBM is not a 4-letter word
• Realizing the value of pharmacy with an integrated pharmacy strategy
• Digital Programs to Enhance Patient Care

Learn more about Maxor today!

Fill out the form below to learn more about how Maxor helps optimize the pharmacy experience for your patients and your employees through customized pharmacy benefit offerings, providing access to prescription medications and home therapies through home delivery and specialty pharmacies, and delivering clinical and financial value with our end-to-end pharmacy management, 340B optimization, and specialty pharmacy solutions.

The post MaxorPlus Named Top Workplace for Fourth Year in a Row appeared first on VytlOne.

• Mark McCullough named Chief Financial Officer
• Jessica Lee named Chief Compliance and Ethics Officer
• Joel Wright named President, Pharmacy Services

Plano, TX — January 3, 2024 — Maxor National Pharmacy Services (“Maxor”) today announced the appointment of three new executives. Mark McCullough joins Maxor as Chief Financial Officer, Jessica Lee as Chief Compliance and Ethics Officer, and Joel Wright as President, Pharmacy Services. All three will serve on the company’s executive leadership team and report to Maxor CEO, Mike Ellis.

“It’s an exciting time for Maxor as we accelerate our strategy, bringing our full suite of clinically integrated pharmacy care solutions to serve our customers, their patients, and employees,” said CEO, Mike Ellis. “We are deepening our bench of talent, and our leaders across our business continue to deploy our innovative, best-in-class, set of capabilities to deliver exceptional pharmacy care, lower costs, and improve patient care.”

Mark McCullough named Chief Financial Officer

McCullough joins the company as Chief Financial Officer and brings more than 25 years of financial and operational leadership experience in the healthcare industry.

“We are pleased to welcome Mark as the new CFO of Maxor,” said Ellis. “Mark has deep financial and operational expertise in pharmacy, health systems, and PBMs. His exceptional experience and leadership will help us execute our growth strategy and deliver value for our customers.”

Most recently, McCullough served as Chief Operating Officer and CFO of Geisinger Health Plans. Prior to that, he served as Chief Financial Officer and Chief Operating Officer of Humana Pharmacy Solutions and was President of Kindred Pharmacy Services. McCullough is a certified public accountant.

Jessica Lee named Chief Compliance and Ethics Officer

Lee joins the executive leadership team in the newly created role of Chief Compliance and Ethics Officer and will oversee the company’s Compliance function. This position has a dual reporting structure to the CEO and the Chair of the Ethics, Compliance and Quality Committee of the Board of Directors. Lee has over a decade of experience managing compliance programs in the healthcare industry with specialization in regulatory oversight and risk assessments in pharmacy and drug benefits.

“Maxor is deeply committed to quality, integrity, and regulatory compliance,” said Ellis. “Jess brings industry knowledge and experience in regulatory and compliance matters. Her leadership and expertise will build upon our strong culture and legacy of quality and compliance to deliver a best-in-class compliance program across our organization.”

Most recently, Lee served as Vice President, Plan Chief Compliance Officer within Managed Health Services at Centene. Prior to that, Lee held senior compliance leadership positions at Cigna, Express Scripts.

Joel Wright named President, Pharmacy Services

Wright joins the executive leadership team as President of Pharmacy Services, which provides full-spectrum, integrated pharmacy management services to hospitals and health centers.

“Joel is an exceptional leader and brings tremendous experience in pharmacy services to Maxor,” said Ellis. “His track record of bringing patient-focused, customer-driven, services to the market will continue to advance our work of delivering integrated pharmacy solutions to best serve our customers and their patients.”

Wright brings more than 30 years of pharmacy management experience, most recently serving as Chief Executive Officer of AllianceRx, the joint venture between Walgreens and Prime Therapeutics. Before leading AllianceRx, Wright led the Specialty Solutions division at Walgreens, and held several leadership roles at Walgreens during his 22-year tenure with the company.

About Maxor

Maxor is a leading pharmacy care solutions company dedicated to improving patient outcomes and lowering the total cost of care through our clinically integrated set of pharmacy care services. Our teams help optimize the pharmacy experience for patients, our customers, their employees, and members whether it’s through our customized pharmacy benefit offerings; providing access to prescription medications and therapies through our home delivery and specialty pharmacies; or delivering clinical and financial value with our end-to-end pharmacy management solutions. With a legacy of exceptional service and deep clinical and pharmacy expertise, Maxor has been a trusted partner enabling pharmacy care since 1926.

Learn more at Maxor.com.

Questions? Contact Krysta Butler:

• 469-891-5153
• kkbutler@maxor.com

The post Maxor appoints three new executives to its executive leadership team appeared first on VytlOne.

“From the day we opened the Tempe office, we invested heavily in our people’s satisfaction and success while building a strong culture. We understand the importance of employee recognition and how that relates to satisfaction; however, we also realize that building detailed career plans and helping our team members grow in their careers is equally important – we place significant focus on culture, recognition and career development. “

Mitch Mann, Vice President, Member Services

READ PRESS RELEASE

Learn more about MaxorPlus:

• Why MaxorPlus?
• Top Workplace 2021
• Connect with MaxorPlus

If you’d like to partner with MaxorPlus, please contact sales@maxor.com.

The post MaxorPlus wins Top Workplace for the second year in a row appeared first on VytlOne.

“Our patients have complex needs and complex treatment plans. We strive to go above and beyond while providing highly specialized care for these individuals,” said Christa Larkin, Senior Vice President, PBM and Specialty Operations. “This is an important milestone and recognition for our specialty business.”

Christa Larkin, Senior Vice President, PBM and Specialty Operations

READ PRESS RELEASE

Learn more about Maxor Specialty Pharmacy:

• Why Maxor Specialty?
• Provider Services
• Manufacturer Services
• Infusion Services
• Rare Disease Center of Excellence

If you’d like to partner with Maxor Specialty Pharmacy, please contact Bill Aikins, baikins@maxor.com

The post Maxor Specialty Pharmacy receives Rare and Orphan Pharmacy Designation appeared first on VytlOne.

“We are proud to have our Tempe office honored as 2021 Top Workplace,” said Jen Gallego, President, MaxorPlus. “Our team showed great strength, compassion, and spirit during the past year of uncertainties and unique circumstances. They always put our members and clients first, and they showed amazing compassion and resiliency throughout it all. Thank you, Team Tempe, for always bringing your best every single day.”

Jen Gallego, President, MaxorPlus

READ PRESS RELEASE

The post Az Central Names MaxorPlus A Winner Of The Arizona Top Workplaces 2021 Award appeared first on VytlOne.

“Michael is recognized nationally as one of the premier thought leaders in the Specialty Industry. His leadership has helped transform Maxor’s technology, analytics, clinical programs and the overall patient experience. I look forward to the significant contributions Michael will undoubtedly have as Chairman of NASP.”

Mike Ellis, Chief Executive Officer, Maxor

READ PRESS RELEASE

The post Maxor Chief Pharmacy Officer, Michael Einodshofer, officially becomes Chairman of the Board during NASP 2020 appeared first on VytlOne.

“Even though our teams have operated seamlessly over the years, bringing us together under one name strengthens our identity in the marketplace,” she said. “One organization with one mission to serve patients with highly complex conditions … now all under one name.”

Suzanne Hansen, Executive Vice President, Maxor

READ PRESS RELEASE

The post Maxor Announces Rebranding Of Maxor Specialty Pharmacy appeared first on VytlOne.

READ PRESS RELEASE

The post Neurelis announces commercial availability of Valtoco® (Diazepam nasal spray) for seizure cluster rescue appeared first on VytlOne.